XOMA Corporation (XOMA)
USD 19.49
(-1.62%)
USD 19.49
(-1.62%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 118.51 Million USD | 348482.35% |
| 2022 | 34 Thousand USD | 0.0% |
| 2021 | 34 Thousand USD | -99.74% |
| 2020 | 12.99 Million USD | -52.75% |
| 2019 | 27.5 Million USD | 26.79% |
| 2018 | 21.69 Million USD | 48.85% |
| 2017 | 14.57 Million USD | -42.43% |
| 2016 | 25.31 Million USD | -40.8% |
| 2015 | 42.75 Million USD | 162.47% |
| 2014 | 16.29 Million USD | -53.66% |
| 2013 | 35.15 Million USD | -6.65% |
| 2012 | 37.65 Million USD | 12.32% |
| 2011 | 33.52 Million USD | 144.81% |
| 2010 | 13.69 Million USD | 2.65% |
| 2009 | 13.34 Million USD | -78.92% |
| 2008 | 63.27 Million USD | 24.43% |
| 2007 | 50.85 Million USD | -48.23% |
| 2006 | 98.21 Million USD | 63.69% |
| 2005 | 60 Million USD | 46.58% |
| 2004 | 40.93 Million USD | 1.88% |
| 2003 | 40.17 Million USD | -36.97% |
| 2002 | 63.74 Million USD | 21.71% |
| 2001 | 52.37 Million USD | 31.43% |
| 2000 | 39.84 Million USD | 14.84% |
| 1999 | 34.7 Million USD | 30.94% |
| 1998 | 26.5 Million USD | 6.85% |
| 1997 | 24.8 Million USD | 74.65% |
| 1996 | 14.2 Million USD | 84.42% |
| 1995 | 7.7 Million USD | 7600.0% |
| 1994 | 100 Thousand USD | -75.0% |
| 1993 | 400 Thousand USD | -63.64% |
| 1992 | 1.1 Million USD | -26.67% |
| 1991 | 1.5 Million USD | -97.45% |
| 1990 | 58.9 Million USD | -23.21% |
| 1989 | 76.7 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 115.07 Million USD | 0.48% |
| 2024 Q1 | 114.52 Million USD | -3.37% |
| 2023 FY | 118.51 Million USD | 348482.35% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q4 | 118.51 Million USD | 0.0% |
| 2022 Q4 | 34 Thousand USD | -60.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2022 FY | 34 Thousand USD | 0.0% |
| 2022 Q3 | 85 Thousand USD | 0.0% |
| 2021 Q3 | 85 Thousand USD | -36.09% |
| 2021 FY | 34 Thousand USD | -99.74% |
| 2021 Q1 | 11.83 Million USD | -8.9% |
| 2021 Q4 | 34 Thousand USD | -60.0% |
| 2021 Q2 | 133 Thousand USD | -98.88% |
| 2020 Q2 | 23.81 Million USD | -6.62% |
| 2020 FY | 12.99 Million USD | -52.75% |
| 2020 Q3 | 21.26 Million USD | -10.72% |
| 2020 Q4 | 12.99 Million USD | -38.9% |
| 2020 Q1 | 25.5 Million USD | -7.25% |
| 2019 FY | 27.5 Million USD | 26.79% |
| 2019 Q3 | 33.88 Million USD | 16.23% |
| 2019 Q2 | 29.15 Million USD | 6.95% |
| 2019 Q4 | 27.5 Million USD | -18.84% |
| 2019 Q1 | 27.26 Million USD | 25.68% |
| 2018 FY | 21.69 Million USD | 48.85% |
| 2018 Q1 | 14.57 Million USD | 0.0% |
| 2018 Q4 | 21.69 Million USD | -1.56% |
| 2018 Q3 | 22.03 Million USD | 48.35% |
| 2018 Q2 | 14.85 Million USD | 1.93% |
| 2017 Q4 | 14.57 Million USD | 1.75% |
| 2017 FY | 14.57 Million USD | -42.43% |
| 2017 Q1 | 14.08 Million USD | -44.35% |
| 2017 Q2 | 14.32 Million USD | 1.68% |
| 2017 Q3 | 14.32 Million USD | 0.0% |
| 2016 Q1 | 36 Million USD | -15.79% |
| 2016 Q2 | 34.38 Million USD | -4.5% |
| 2016 Q4 | 25.31 Million USD | -22.73% |
| 2016 Q3 | 32.75 Million USD | -4.73% |
| 2016 FY | 25.31 Million USD | -40.8% |
| 2015 Q4 | 42.75 Million USD | -3.83% |
| 2015 FY | 42.75 Million USD | 162.47% |
| 2015 Q3 | 44.46 Million USD | 38.03% |
| 2015 Q2 | 32.21 Million USD | 1.99% |
| 2015 Q1 | 31.58 Million USD | 93.89% |
| 2014 Q1 | 34.65 Million USD | -1.4% |
| 2014 Q2 | 17.33 Million USD | -50.0% |
| 2014 Q3 | 16.55 Million USD | -4.47% |
| 2014 FY | 16.29 Million USD | -53.66% |
| 2014 Q4 | 16.29 Million USD | -1.61% |
| 2013 Q1 | 37.01 Million USD | -1.69% |
| 2013 Q4 | 35.15 Million USD | -4.85% |
| 2013 Q2 | 36.87 Million USD | -0.39% |
| 2013 Q3 | 36.94 Million USD | 0.18% |
| 2013 FY | 35.15 Million USD | -6.65% |
| 2012 Q2 | 32.67 Million USD | -2.66% |
| 2012 Q4 | 37.65 Million USD | 0.01% |
| 2012 Q3 | 37.64 Million USD | 15.22% |
| 2012 FY | 37.65 Million USD | 12.32% |
| 2012 Q1 | 33.56 Million USD | 0.13% |
| 2011 FY | 33.52 Million USD | 144.81% |
| 2011 Q1 | 26.24 Million USD | 91.62% |
| 2011 Q2 | 27.03 Million USD | 3.01% |
| 2011 Q3 | 26.64 Million USD | -1.41% |
| 2011 Q4 | 33.52 Million USD | 25.8% |
| 2010 Q3 | 13.5 Million USD | -0.04% |
| 2010 Q4 | 13.69 Million USD | 1.44% |
| 2010 Q1 | 13.34 Million USD | 0.0% |
| 2010 FY | 13.69 Million USD | 2.65% |
| 2010 Q2 | 13.5 Million USD | 1.23% |
| 2009 Q4 | 13.34 Million USD | 1.61% |
| 2009 Q1 | 12.88 Million USD | -79.64% |
| 2009 Q2 | 13.12 Million USD | 1.93% |
| 2009 Q3 | 13.12 Million USD | 0.0% |
| 2009 FY | 13.34 Million USD | -78.92% |
| 2008 Q3 | 77.69 Million USD | 1.88% |
| 2008 Q2 | 76.26 Million USD | 78.64% |
| 2008 Q1 | 42.69 Million USD | -16.05% |
| 2008 Q4 | 63.27 Million USD | -18.56% |
| 2008 FY | 63.27 Million USD | 24.43% |
| 2007 Q2 | 49.24 Million USD | 5.49% |
| 2007 Q4 | 50.85 Million USD | 3.25% |
| 2007 FY | 50.85 Million USD | -48.23% |
| 2007 Q3 | 49.24 Million USD | 0.0% |
| 2007 Q1 | 46.68 Million USD | -52.47% |
| 2006 Q3 | 74.19 Million USD | 0.39% |
| 2006 Q2 | 73.9 Million USD | -5.08% |
| 2006 Q1 | 77.86 Million USD | 29.77% |
| 2006 Q4 | 98.21 Million USD | 32.38% |
| 2006 FY | 98.21 Million USD | 63.69% |
| 2005 FY | 60 Million USD | 46.58% |
| 2005 Q1 | 60 Million USD | 46.58% |
| 2005 Q2 | 60 Million USD | 0.0% |
| 2005 Q3 | 68.84 Million USD | 14.74% |
| 2005 Q4 | 60 Million USD | -12.85% |
| 2004 FY | 40.93 Million USD | 1.88% |
| 2004 Q2 | 40.48 Million USD | 0.55% |
| 2004 Q3 | 47.54 Million USD | 17.44% |
| 2004 Q1 | 40.26 Million USD | 0.22% |
| 2004 Q4 | 40.93 Million USD | -13.91% |
| 2003 FY | 40.17 Million USD | -36.97% |
| 2003 Q1 | 71.57 Million USD | 12.28% |
| 2003 Q2 | 75.37 Million USD | 5.32% |
| 2003 Q3 | 77.59 Million USD | 2.94% |
| 2003 Q4 | 40.17 Million USD | -48.22% |
| 2002 Q2 | 58.81 Million USD | 9.99% |
| 2002 Q4 | 63.74 Million USD | 6.6% |
| 2002 FY | 63.74 Million USD | 21.71% |
| 2002 Q1 | 53.47 Million USD | 2.1% |
| 2002 Q3 | 59.8 Million USD | 1.68% |
| 2001 Q3 | 45.19 Million USD | 3.25% |
| 2001 Q4 | 52.37 Million USD | 15.87% |
| 2001 Q2 | 43.77 Million USD | 1.71% |
| 2001 Q1 | 43.03 Million USD | 8.01% |
| 2001 FY | 52.37 Million USD | 31.43% |
| 2000 FY | 39.84 Million USD | 14.84% |
| 2000 Q1 | 40.16 Million USD | 15.74% |
| 2000 Q3 | 36.23 Million USD | 7.7% |
| 2000 Q4 | 39.84 Million USD | 9.96% |
| 2000 Q2 | 33.64 Million USD | -16.22% |
| 1999 Q3 | 30.3 Million USD | -3.19% |
| 1999 Q4 | 34.7 Million USD | 14.52% |
| 1999 Q1 | 26.9 Million USD | 1.51% |
| 1999 FY | 34.7 Million USD | 30.94% |
| 1999 Q2 | 31.3 Million USD | 16.36% |
| 1998 FY | 26.5 Million USD | 6.85% |
| 1998 Q2 | 25.6 Million USD | 1.59% |
| 1998 Q4 | 26.5 Million USD | 1.53% |
| 1998 Q3 | 26.1 Million USD | 1.95% |
| 1998 Q1 | 25.2 Million USD | 1.61% |
| 1997 Q3 | 14.5 Million USD | 1.4% |
| 1997 Q4 | 24.8 Million USD | 71.03% |
| 1997 FY | 24.8 Million USD | 74.65% |
| 1997 Q2 | 14.3 Million USD | 2.14% |
| 1997 Q1 | 14 Million USD | -1.41% |
| 1996 Q1 | - USD | -100.0% |
| 1996 FY | 14.2 Million USD | 84.42% |
| 1996 Q3 | 5 Million USD | 0.0% |
| 1996 Q4 | 14.2 Million USD | 184.0% |
| 1996 Q2 | 5 Million USD | 0.0% |
| 1995 FY | 7.7 Million USD | 7600.0% |
| 1995 Q4 | 7.7 Million USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q1 | - USD | -100.0% |
| 1995 Q3 | - USD | 0.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| 1994 Q1 | - USD | -100.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | 100 Thousand USD | -75.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | -100.0% |
| 1993 FY | 400 Thousand USD | -63.64% |
| 1993 Q1 | 10.4 Million USD | 845.45% |
| 1993 Q4 | 400 Thousand USD | 0.0% |
| 1992 FY | 1.1 Million USD | -26.67% |
| 1992 Q2 | 1.3 Million USD | -7.14% |
| 1992 Q4 | 1.1 Million USD | -8.33% |
| 1992 Q1 | 1.4 Million USD | -6.67% |
| 1992 Q3 | 1.2 Million USD | -7.69% |
| 1991 FY | 1.5 Million USD | -97.45% |
| 1991 Q3 | 1.6 Million USD | -5.88% |
| 1991 Q4 | 1.5 Million USD | -6.25% |
| 1991 Q1 | 57.8 Million USD | -1.87% |
| 1991 Q2 | 1.7 Million USD | -97.06% |
| 1990 Q3 | 58.9 Million USD | -20.73% |
| 1990 Q1 | 75.3 Million USD | -1.83% |
| 1990 FY | 58.9 Million USD | -23.21% |
| 1990 Q2 | 74.3 Million USD | -1.33% |
| 1990 Q4 | 58.9 Million USD | 0.0% |
| 1989 Q2 | 78.8 Million USD | 0.0% |
| 1989 Q3 | 77.6 Million USD | -1.52% |
| 1989 Q4 | 76.7 Million USD | -1.16% |
| 1989 FY | 76.7 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -66.406% |
| Alkermes plc | 287.73 Million USD | 58.809% |
| Agenus Inc. | 137.32 Million USD | 13.695% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 94.942% |
| Aptorum Group Limited | 3.05 Million USD | -3775.037% |
| Ardelyx, Inc. | 51.54 Million USD | -129.922% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -13.297% |
| Bicycle Therapeutics plc | 40.08 Million USD | -195.704% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -17.813% |
| ChromaDex Corporation | 2.57 Million USD | -4502.641% |
| Chimerix, Inc. | 125 Thousand USD | -94714.4% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -3559.509% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -357.457% |
| CRISPR Therapeutics AG | 223 Million USD | 46.855% |
| Precision BioSciences, Inc. | 7.72 Million USD | -1434.611% |
| Dyadic International, Inc. | 88.87 Thousand USD | -133261.089% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -538618.182% |
| Fortress Biotech, Inc. | 60.85 Million USD | -94.752% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -192624.73% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -3018.074% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -131405.481% |
| Incyte Corporation | 29.16 Million USD | -306.412% |
| IO Biotech, Inc. | 1.83 Million USD | -6344.698% |
| Jaguar Health, Inc. | 30.99 Million USD | -282.402% |
| Novavax, Inc. | 168.01 Million USD | 29.46% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -414.736% |
| Opthea Limited | 200.53 Million USD | 40.899% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -1959.392% |
| ContextLogic Inc. | 6 Million USD | -1875.3% |
| MiMedx Group, Inc. | 48.09 Million USD | -146.404% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -489.671% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -309419.208% |
| NextCure, Inc. | 5.94 Million USD | -1892.234% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -81636.552% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -436.014% |
| PDS Biotechnology Corporation | 19.5 Million USD | -507.592% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -2.631% |
| Pharming Group N.V. | 166.1 Million USD | 28.649% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -1807.581% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -253.627% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -9727.363% |
| Acelyrin, Inc. | 1.19 Million USD | -9826.131% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -25664.783% |
| Summit Therapeutics Inc. | 103.29 Million USD | -14.743% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -3044.548% |
| Senti Biosciences, Inc. | 33.53 Million USD | -253.384% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -2383.092% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -242.974% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -96.479% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -7448.917% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -366.533% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -13.59% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -16090.984% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -959.047% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 14.306% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -781.896% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -690.12% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 37.927% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -125.071% |
| Fortress Biotech, Inc. | 60.85 Million USD | -94.752% |
| Precigen, Inc. | 5.89 Million USD | -1910.483% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -182.266% |
| AlloVir, Inc. | 16.64 Million USD | -611.905% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -80.236% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -21.732% |
| ImmuCell Corporation | 10.54 Million USD | -1024.406% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -10434.933% |
| Onconetix, Inc. | 118.85 Thousand USD | -99614.783% |
| PureTech Health plc | 18.25 Million USD | -549.414% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -119615.152% |
| Elevation Oncology, Inc. | 30.13 Million USD | -293.264% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -356.47% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -176.433% |
| Innoviva, Inc. | 446.23 Million USD | 73.44% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -14127.851% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -177205.368% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 42.736% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -66.467% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -3617.629% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -11317.919% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -430.852% |
| Aptose Biosciences Inc. | 621 Thousand USD | -18985.024% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -11623.614% |
| Century Therapeutics, Inc. | 46.65 Million USD | -154.014% |
| Kura Oncology, Inc. | 9.33 Million USD | -1170.017% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -343.888% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -85782.609% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -1162.845% |
| Autolus Therapeutics plc | 47.91 Million USD | -147.356% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -2315.777% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -1649.86% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | 9.293% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -1362.283% |
| IGM Biosciences, Inc. | 34.67 Million USD | -241.826% |
| INmune Bio, Inc. | 397 Thousand USD | -29753.401% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 31.789% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -2823.295% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -80552.471% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -138.122% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -117.185% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -159.379% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 74.963% |
| Verastem, Inc. | 40.08 Million USD | -195.659% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -2592.367% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -1078.814% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -1706.401% |
| Histogen Inc. | 4.38 Million USD | -2603.422% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -13337.415% |
| Organovo Holdings, Inc. | 888 Thousand USD | -13246.622% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -295.06% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -2725.894% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -527.245% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -56.563% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -127196.357% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -357.475% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -44288.764% |
| Amarin Corporation plc | 8.73 Million USD | -1256.507% |
| Mesoblast Limited | 100.48 Million USD | -17.948% |
| Turnstone Biologics Corp. | 1.18 Million USD | -9867.872% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -51.308% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -108632.11% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -44.518% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 37.604% |
| Better Therapeutics, Inc. | 10.34 Million USD | -1045.323% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -412.51% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -27.394% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -9073.22% |
| Gritstone bio, Inc. | 40.14 Million USD | -195.232% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -6433.517% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | 22.836% |
| Insmed Incorporated | 1.19 Billion USD | 90.068% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -1766.425% |
| OmniAb, Inc. | 22.07 Million USD | -436.888% |
| Alector, Inc. | 30.45 Million USD | -289.145% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -16.716% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -1372.822% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 72.218% |
| Aura Biosciences, Inc. | 16.87 Million USD | -602.537% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -108.314% |
| Immunic, Inc. | 639 Thousand USD | -18447.418% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -297.458% |
| Veracyte, Inc. | 7.52 Million USD | -1474.99% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 81.621% |
| FibroGen, Inc. | 89.69 Million USD | -32.132% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2632.718% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -90466.47% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 97.68% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -320218.919% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -5885.758% |
| TG Therapeutics, Inc. | 100.11 Million USD | -18.378% |
| Galecto, Inc. | 66 Thousand USD | -179472.727% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -87045.588% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 92.74% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -1870.374% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -2095.998% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -6433.517% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -452.609% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -224.218% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -22824.178% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -161.999% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -287.643% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -164.537% |
| Vaxxinity, Inc. | 13.26 Million USD | -793.666% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 85.391% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -26292.876% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -1248.481% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 95.615% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -37405.696% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -2558.546% |
| Ainos, Inc. | 5.92 Million USD | -1901.467% |
| Pluri Inc. | 29.05 Million USD | -307.937% |
| Prothena Corporation plc | 10.72 Million USD | -1005.475% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -497.038% |
| Celularity Inc. | 26.17 Million USD | -352.756% |
| Rallybio Corporation | 173 Thousand USD | -68407.514% |
| Cue Biopharma, Inc. | 4.2 Million USD | -2720.514% |
| MeiraGTx Holdings plc | 72.11 Million USD | -64.337% |
| Omeros Corporation | 329.7 Million USD | 64.053% |
| Humacyte, Inc. | 38.6 Million USD | -207.041% |
| Immunocore Holdings plc | 82.64 Million USD | -43.408% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -7247.675% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -3213.335% |
| Blueprint Medicines Corporation | 610.96 Million USD | 80.601% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -8028.807% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -24.508% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -143.443% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -30.381% |
| Pulmatrix, Inc. | 8.32 Million USD | -1323.298% |
| Elicio Therapeutics, Inc. | 6 Million USD | -1872.998% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -815.55% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -22.503% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -25170.362% |
| Cytokinetics, Incorporated | 607.37 Million USD | 80.487% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -1263.53% |
| Nutriband Inc. | 79.82 Thousand USD | -148370.423% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -2543.131% |
| Vor Biopharma Inc. | 31.83 Million USD | -272.347% |
| Roivant Sciences Ltd. | 477.85 Million USD | 75.198% |
| Evogene Ltd. | 10.65 Million USD | -1012.532% |
| ProKidney Corp. | 3.61 Million USD | -3183.047% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -15515.02% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -450093.725% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 93.172% |
| CorMedix Inc. | 517.01 Thousand USD | -22823.602% |
| BioLineRx Ltd. | 6.62 Million USD | -1688.141% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -221.728% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -65.203% |
| Atai Life Sciences N.V. | 15.21 Million USD | -679.16% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -13969.272% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -46377.647% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -174.665% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -28760.371% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -8557.268% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -17773.349% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 33.443% |
| Biomea Fusion, Inc. | 7.83 Million USD | -1413.64% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 58.3% |
| Mereo BioPharma Group plc | 5.3 Million USD | -2136.189% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -5412.465% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -20056.122% |
| Absci Corporation | 4.66 Million USD | -2443.305% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -928.624% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -422.221% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -1084.588% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -930.143% |
| Allakos Inc. | 38.21 Million USD | -210.135% |
| Imunon, Inc. | 1.13 Million USD | -10302.767% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -1273.485% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -14076.794% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -1185080.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -34.152% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -2416.84% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -1077.058% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -219.636% |
| aTyr Pharma, Inc. | 13.76 Million USD | -760.885% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -1400.418% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -374.756% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -486.578% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -790020.0% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -42503.257% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -719.918% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 92.095% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -86934.875% |
| UroGen Pharma Ltd. | 98.55 Million USD | -20.261% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 20.519% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -521.587% |
| Entera Bio Ltd. | 256 Thousand USD | -46196.094% |
| GH Research PLC | 631 Thousand USD | -18682.567% |
| Lisata Therapeutics, Inc. | 137.00 USD | -86509389.051% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -18360.748% |
| Xencor, Inc. | 14.64 Million USD | -709.439% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -78780.007% |
| Replimune Group, Inc. | 71.99 Million USD | -64.631% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -78912.0% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -1591.664% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -86934.875% |
| Portage Biotech Inc. | 7000.00 USD | -1693014.286% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -17773.349% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -8193.772% |
| OncoCyte Corporation | 2.2 Million USD | -5277.405% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -177043.711% |
| Purple Biotech Ltd. | 163 Thousand USD | -72610.429% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -4575.266% |
| scPharmaceuticals Inc. | 38.81 Million USD | -205.372% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -369.49% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -162253.425% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -6296.006% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -349.818% |
| Curis, Inc. | 1.48 Million USD | -7859.57% |
| Daré Bioscience, Inc. | 3.91 Million USD | -2928.304% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -16886.592% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -1975200.0% |
| BeiGene, Ltd. | 197.61 Million USD | 40.027% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -12902.523% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -47.09% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -128.407% |
| bluebird bio, Inc. | 224.41 Million USD | 47.189% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 80.017% |
| DBV Technologies S.A. | 4.52 Million USD | -2518.604% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -8744.627% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -1116.567% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -3046.217% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 68.585% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -176.414% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -6802.621% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -12671.336% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -578.525% |
| MacroGenics, Inc. | 30.19 Million USD | -292.496% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -569.48% |
| Prime Medicine, Inc. | 4.35 Million USD | -2620.174% |
| Aditxt, Inc. | 1.04 Million USD | -11276.883% |
| Adagene Inc. | 13.54 Million USD | -775.315% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -762.765% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 77.151% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -593.372% |
| SciSparc Ltd. | 24 Thousand USD | -493725.0% |
| Vericel Corporation | 81.85 Million USD | -44.788% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -44.505% |
| Generation Bio Co. | 89.77 Million USD | -32.018% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -434.226% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 41.269% |
| Invivyd, Inc. | 722 Thousand USD | -16315.235% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -144.357% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -4053557.485% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -2998.51% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -515195.652% |
| 2seventy bio, Inc. | 244.01 Million USD | 51.43% |
| ADMA Biologics, Inc. | 130.59 Million USD | 9.247% |
| Clene Inc. | 7.15 Million USD | -1557.131% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -3410.335% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 52.137% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -10664.578% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -44987.022% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 38.471% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -317.273% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -1129.567% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -6.13% |
| Evaxion Biotech A/S | 8.48 Million USD | -1296.177% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -58.182% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -83.138% |
| Trevena, Inc. | 35.23 Million USD | -236.384% |
| Surrozen, Inc. | 882 Thousand USD | -13337.415% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -1806.66% |
| Cingulate Inc. | 135.09 Thousand USD | -87626.778% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -403.496% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -147.946% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -65743.333% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -366.992% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -579.693% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -12562.179% |
| Statera Biopharma, Inc. | 11.43 Million USD | -936.799% |
| ImmunityBio, Inc. | 836.95 Million USD | 85.839% |
| Korro Bio, Inc. | 31.21 Million USD | -279.671% |
| Kineta, Inc. | 150 Thousand USD | -78912.0% |
| BioVie Inc. | 349.89 Thousand USD | -33772.544% |
| Codexis, Inc. | 12.24 Million USD | -868.047% |
| Celularity Inc. | 26.17 Million USD | -352.756% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -149.223% |
| Celcuity Inc. | 37.03 Million USD | -220.013% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -67108.03% |
| Cibus, Inc. | 17.67 Million USD | -570.578% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -3407.487% |
| Kodiak Sciences Inc. | 100 Million USD | -18.518% |
| Annexon, Inc. | 29.19 Million USD | -306.023% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -83.388% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -10463.102% |
| Avalo Therapeutics, Inc. | 2 Million USD | -5825.9% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 91.537% |
| Eyenovia, Inc. | 8.95 Million USD | -1223.154% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -80.505% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -1355.637% |
| Arcellx, Inc. | 50.84 Million USD | -133.115% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -8028.807% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -458.047% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -11133.934% |
| Moolec Science SA | 99.04 Thousand USD | -119559.552% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -329.087% |
| Geron Corporation | 35.05 Million USD | -238.13% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -19953.807% |
| Royalty Pharma plc | 6.13 Billion USD | 98.068% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -7117.905% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -373279.119% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -412.001% |
| Humacyte, Inc. | 38.6 Million USD | -207.041% |
| Structure Therapeutics Inc. | 4.01 Million USD | -2853.352% |
| 89bio, Inc. | 24.79 Million USD | -377.992% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -853.177% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -6251.447% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -11384.302% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -19.104% |
| Notable Labs, Ltd. | 1.52 Million USD | -7666.579% |
| Liquidia Corporation | 2.36 Million USD | -4913.452% |
| Mustang Bio, Inc. | 1.97 Million USD | -5891.81% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -762.765% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -1604.559% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -37287.382% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -137.621% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -1134.048% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -180873.904% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -87045.588% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -1792.05% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -91067.692% |
| PepGen Inc. | 17.1 Million USD | -593.088% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -24903.797% |
| United Therapeutics Corporation | 300 Million USD | 60.494% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -395.042% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -2747.039% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -20404.844% |
| XOMA Corporation | 118.51 Million USD | 0.0% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -320218.919% |
| Bionomics Limited | 117.62 Million USD | -0.757% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -12602.894% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -2012.62% |
| uniQure N.V. | 130.06 Million USD | 8.878% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -102.284% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -17176.676% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2632.718% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -8457.256% |
| Altimmune, Inc. | 175 Thousand USD | -67624.571% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 69.443% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -2012.62% |
| Compugen Ltd. | 719 Thousand USD | -16383.727% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -2239.479% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -40.167% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -1093.535% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -1757.94% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -29.655% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -1093.535% |
| Instil Bio, Inc. | 81.42 Million USD | -45.551% |
| argenx SE | 15.35 Million USD | -671.903% |
| Immunome, Inc. | 1.34 Million USD | -8744.627% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -22011.567% |
| Verona Pharma plc | 48.37 Million USD | -145.004% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -1186.003% |
| Shattuck Labs, Inc. | 3.4 Million USD | -3379.683% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -139332.941% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -70446.429% |
| Moolec Science SA | 99.04 Thousand USD | -119559.552% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -974.305% |
| AnaptysBio, Inc. | 16.03 Million USD | -639.028% |
| Design Therapeutics, Inc. | 2.33 Million USD | -4977.892% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -437704.292% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -1875.3% |
| Achilles Therapeutics plc | 1.07 Million USD | -10914.684% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -1186.003% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -594392.376% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -607.89% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -148370.423% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -1588400.201% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -911576.923% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 65.394% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -384.063% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -4640.739% |
| Palisade Bio, Inc. | 90 Thousand USD | -131586.667% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -60991.753% |
| Beam Therapeutics Inc. | 159.91 Million USD | 25.885% |
| Neurogene Inc. | 13.37 Million USD | -786.248% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 61.322% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -351.274% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -198017.749% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -11751.8% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -192.579% |
| Athira Pharma, Inc. | 1.21 Million USD | -9638.537% |
| Vaccinex, Inc. | 26 Thousand USD | -455738.462% |
| HCW Biologics Inc. | 6.3 Million USD | -1779.95% |
| XOMA Corporation | 118.51 Million USD | 0.0% |
| Nektar Therapeutics | 112.62 Million USD | -5.232% |
| Arvinas, Inc. | 800 Thousand USD | -14714.75% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -719.918% |
| Merus N.V. | 10.48 Million USD | -1030.034% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -696.224% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -782.553% |
| Rezolute, Inc. | 1.66 Million USD | -7039.639% |
| Clene Inc. | 7.15 Million USD | -1557.131% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -161483.138% |
| BeyondSpring Inc. | 3.36 Million USD | -3423.127% |
| Synlogic, Inc. | 12.49 Million USD | -848.827% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -262.929% |
| Krystal Biotech, Inc. | 6.62 Million USD | -1690.302% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 30.658% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -1876.618% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -250091.045% |
| MannKind Corporation | 252.15 Million USD | 52.997% |
| Ikena Oncology, Inc. | 7.18 Million USD | -1550.669% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -59456.784% |
| Gossamer Bio, Inc. | 197.4 Million USD | 39.962% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -22691.923% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 57.872% |
| Mural Oncology plc | 8.91 Million USD | -1230.019% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -170.985% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -8153.343% |
| Champions Oncology, Inc. | 6.09 Million USD | -1845.15% |
| REGENXBIO Inc. | 82.22 Million USD | -44.144% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -23891.352% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -2572.936% |
| Vaxart, Inc. | 2.62 Million USD | -4418.414% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -43531.986% |
| Cellectis S.A. | 36.24 Million USD | -227.027% |
| Longeveron Inc. | 1.44 Million USD | -8084.945% |
| Repare Therapeutics Inc. | 1.01 Million USD | -11634.455% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 89.535% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -164.732% |
| Revolution Medicines, Inc. | 80.57 Million USD | -47.09% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -3594.451% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -66859.322% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -96256.098% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 83.646% |
| Denali Therapeutics Inc. | 44.98 Million USD | -163.485% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -847.822% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -87626.778% |
| Passage Bio, Inc. | 22.92 Million USD | -417.072% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -1862.543% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -18218.083% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -487.741% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -24087.347% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -28987.241% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -9876.263% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -25333.047% |
| OmniAb, Inc. | 22.07 Million USD | -436.888% |
| Anew Medical, Inc. | 1.54 Million USD | -7595.974% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -300.941% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -1212.056% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -281.209% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -2823.295% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -129.878% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -1761.442% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -738.828% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -17536.607% |
| Alumis Inc. Common Stock | 30.86 Million USD | -284.051% |
| Equillium, Inc. | 384 Thousand USD | -30764.063% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -1824.306% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | 21.537% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -142.472% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -98417.065% |
| Dominari Holdings Inc. | 3.02 Million USD | -3814.069% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -599293.112% |
| vTv Therapeutics Inc. | 169 Thousand USD | -70028.994% |
| Bio-Techne Corporation | 319 Million USD | 62.847% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -107.97% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 33.628% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -669.248% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -857.102% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -2365.529% |
| Nkarta, Inc. | 82.27 Million USD | -44.06% |
| BioCardia, Inc. | 982 Thousand USD | -11969.043% |
| Iterum Therapeutics plc | 18.95 Million USD | -525.227% |